Capricor Therapeutics, Inc. (CAPR) vs Tilray Brands, Inc. (TLRY)
A side-by-side comparison of Capricor Therapeutics, Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAPR
Capricor Therapeutics, Inc.
$7.66HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
TLRY
Tilray Brands, Inc.
$3.82HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — CAPR vs TLRY
growth of $100 · dividends reinvested · last 8yCAPR -45.6% (-7.3%/yr)TLRY -98.3% (-40.1%/yr)CAPR compounded faster over this window
Log scale — wide-divergence pair
CAPR TLRY
CAPR vs TLRY: by the numbers
- •CAPR is the larger company ($441M vs $427M market cap).
- •Both run net losses; CAPR's is the smaller (0.00% vs -12.90% net margin).
Metrics side by side
Valuation
| Metric | CAPR | TLRY |
|---|---|---|
| P/S ratio | N/A | 0.37 |
| P/B ratio | 1.79 | 0.26 |
| EV / EBITDA | 0.44 | 23.04 |
Profitability
| Metric | CAPR | TLRY |
|---|---|---|
| Gross margin | 0.00% | 27.57% |
| Operating margin | 0.00% | -5.18% |
| Net margin | 0.00% | -12.90% |
| ROE | -52.56% | -9.23% |
| ROIC | -40.25% | -2.98% |
Growth (annualized)
| Metric | CAPR | TLRY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.11% |
| Total return CAGR (5Y) | 15.17% | -49.30% |
Frequently asked
- How have CAPR and TLRY total returns compared?
- Over the past 5 years, CAPR delivered 15.17% and TLRY delivered -49.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Capricor Therapeutics ROETilray Brands ROECapricor Therapeutics operating marginTilray Brands operating marginCapricor Therapeutics revenue growthTilray Brands revenue growthCapricor Therapeutics free cash flowTilray Brands free cash flow
Capricor Therapeutics & Tilray Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.